含CuO@CrO纳米颗粒的羟丙基甲基纤维素-胶原蛋白纳米复合材料的绿色合成:对MG-63骨肉瘤细胞的抗菌、抗氧化和抗癌活性
Green synthesis of hydroxypropyl methylcellulose-collagen nanocomposites containing CuO@CrO nanoparticles: Antimicrobial, antioxidant, and anticancer activities against MG-63 osteosarcoma cells.
作者信息
Selim Samy, Almuhayawi Mohammed S, Gattan Hattan S, Alruhaili Mohammed H, Alharbi Mohanned T, Al Jaouni Soad K, Saddiq Amna A, Alahmadi Abrar
机构信息
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.
Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
出版信息
Int J Biol Macromol. 2025 Aug;319(Pt 3):145498. doi: 10.1016/j.ijbiomac.2025.145498. Epub 2025 Jun 24.
Bimetallic nanoparticles are potential biological materials distinguished by their multifunctional biological characteristics. This study addresses the critical need for multifunctional therapeutic materials that can simultaneously combat antimicrobial resistance, promote wound healing, and provide anticancer activity three major challenges in modern healthcare. This study presents nanocomposite-based polysaccharides, namely hydroxypropyl methylcellulose (HPMC) and collagen, synthesized in situ with bimetallic CuO@CrO nanoparticles. The developed nanocomposites represent a novel approach to creating multifunctional therapeutic platforms with enhanced efficacy compared to conventional monometallic systems. The characterizations were conducted using Fourier transform infrared (FTIR) spectroscopy and X-ray diffraction (XRD), while the topographical analysis was performed through field emission scanning electron microscopy (FE-SEM) coupled with energy dispersive X-ray analysis (EDX) and high-resolution transmission electron microscopy (HR-TEM). The investigation highlighted the development of a nanofilm and detailed the doping of bimetallic CuO@CrO nanoparticles, which are around 20 nm in size. LNC exhibited superior antimicrobial efficacy compared to FNC against S. typhi, E. coli, E. faecalis, S. typhi, and C. albicans, with inhibition zones of 21 ± 0.2, 21 ± 0.1, 26 ± 0.1, 20 ± 0.2, and 30 ± 0.2 mm, respectively. The documented MIC values, bacterial biofilm concentrations, and time-kill kinetics demonstrated the superior efficacy of LNC in comparison to FNC. The highest antioxidant and anticancer efficacy against osteosarcoma MG-63 cells was ascribed to LNC, with IC50 values of 19.49 and 80.78 ± 0.95 μg/mL, in contrast to the IC50 of FNC, which was 68.66 μg/mL and 111.4 ± 0.68 μg/mL, respectively. The wound closure rates were 68.68 % for LNC and 64.26 % for FNC, respectively. These findings highlight the strong potential of the developed nanocomposites for clinical applications in treating bone cancer-related infections and promoting tissue regeneration, marking a significant advancement in multifunctional nanocomposite design through the innovative integration of green synthesis, bimetallic nanoparticles, and a dual-polymer matrix strategy.
双金属纳米颗粒是具有多功能生物学特性的潜在生物材料。本研究满足了对多功能治疗材料的迫切需求,这些材料能够同时应对抗菌耐药性、促进伤口愈合以及提供抗癌活性,这是现代医疗保健中的三大挑战。本研究展示了基于纳米复合材料的多糖,即羟丙基甲基纤维素(HPMC)和胶原蛋白,它们与双金属CuO@CrO纳米颗粒原位合成。所开发的纳米复合材料代表了一种创建多功能治疗平台的新方法,与传统单金属系统相比,其疗效增强。使用傅里叶变换红外(FTIR)光谱和X射线衍射(XRD)进行表征,同时通过场发射扫描电子显微镜(FE-SEM)结合能量色散X射线分析(EDX)和高分辨率透射电子显微镜(HR-TEM)进行形貌分析。该研究突出了纳米薄膜的开发,并详细说明了尺寸约为20纳米的双金属CuO@CrO纳米颗粒的掺杂情况。与FNC相比,LNC对伤寒沙门氏菌、大肠杆菌、粪肠球菌、伤寒沙门氏菌和白色念珠菌表现出更高的抗菌功效,抑菌圈分别为21±0.2、21±0.1、26±0.1、20±0.2和30±0.2毫米。记录的最低抑菌浓度(MIC)值、细菌生物膜浓度和时间杀灭动力学表明,与FNC相比,LNC具有更高的疗效。LNC对骨肉瘤MG-63细胞的抗氧化和抗癌功效最高,IC50值分别为19.49和80.78±0.95微克/毫升,而FNC的IC50值分别为68.66微克/毫升和111.4±0.68微克/毫升。LNC和FNC的伤口闭合率分别为68.68%和64.26%。这些发现突出了所开发的纳米复合材料在治疗骨癌相关感染和促进组织再生的临床应用中的强大潜力,标志着通过绿色合成、双金属纳米颗粒和双聚合物基质策略的创新整合,在多功能纳米复合材料设计方面取得了重大进展。